Moreover, patients with adenocarcinomas with positive epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) alterations show improved survival compared to those without these alterations [13,14]. The gene discussed is ALK; the disease is adenocarcinoma.